KBC Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,732
| Closed | -$48K | – | 1347 |
|
|
2020
Q1 | $48K | Hold |
12,732
| – | – | ﹤0.01% | 1204 |
|
|
2019
Q4 | $65K | Buy |
12,732
+12,707
| +50,828% | +$64.9K | ﹤0.01% | 1399 |
|
|
2019
Q3 | $0 | Sell |
25
-22,147
| -100% | – | ﹤0.01% | 1515 |
|
|
2019
Q2 | $137K | Hold |
22,172
| – | – | ﹤0.01% | 1277 |
|
|
2019
Q1 | $103K | Buy |
22,172
+2,700
| +14% | +$12.5K | ﹤0.01% | 1276 |
|
|
2018
Q4 | $82K | Sell |
19,472
-328,731
| -94% | -$1.38M | ﹤0.01% | 1190 |
|
|
2018
Q3 | $2.18M | Buy |
348,203
+129,580
| +59% | +$812K | 0.02% | 646 |
|
|
2018
Q2 | $1.76M | Hold |
218,623
| – | – | 0.02% | 636 |
|
|
2018
Q1 | $1.63M | Buy |
218,623
+1,051
| +0.5% | +$7.84K | 0.02% | 622 |
|
|
2017
Q4 | $1.3M | Sell |
217,572
-17,205
| -7% | -$102K | 0.01% | 728 |
|
|
2017
Q3 | $1.73M | Buy |
234,777
+21,791
| +10% | +$160K | 0.02% | 644 |
|
|
2017
Q2 | $1.45M | Buy |
212,986
+96,082
| +82% | +$652K | 0.01% | 670 |
|
|
2017
Q1 | $1.1M | Buy |
+116,904
| New | +$1.1M | 0.01% | 840 |
|